大葉大學圖書館 |

High density lipoproteins[electronic resource] :from biological understanding to clinical exploitation /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	572.68
書名/作者:	High density lipoproteins : from biological understanding to clinical exploitation // edited by Arnold von Eckardstein, Dimitris Kardassis.
其他作者:	Eckardstein, Arnold von.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xiii, 694 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	High density lipoproteins.
標題:	Biomedicine.
標題:	Pharmacology/Toxicology.
標題:	Molecular Medicine.
標題:	Human Physiology.
標題:	Immunology.
標題:	Cell Biology.
ISBN:	9783319096650 (electronic bk.)
ISBN:	9783319096643 (paper)
內容註:	Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
摘要、提要註:	In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
電子資源:	http://dx.doi.org/10.1007/978-3-319-09665-0

High density lipoproteins[electronic resource] :from biological understanding to clinical exploitation /
High density lipoproteinsfrom biological understanding to clinical exploitation /[electronic resource] :edited by Arnold von Eckardstein, Dimitris Kardassis. - Cham :Springer International Publishing :2015. - xiii, 694 p. :ill. (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v.2240171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.

In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

ISBN: 9783319096650 (electronic bk.)

Standard No.: 10.1007/978-3-319-09665-0doiSubjects--Topical Terms:

605161
High density lipoproteins.

LC Class. No.: QP99.3.H53

Dewey Class. No.: 572.68

High density lipoproteins[electronic resource] :from biological understanding to clinical exploitation /
LDR:01999nam a2200325 a 4500 001 425807
003 DE-He213
005 20150729151426.0
006 m d
007 cr nn 008maaau
008 151119s2015 gw s 0 eng d
020 $a 9783319096650 (electronic bk.)
020 $a 9783319096643 (paper)
024 7 $a 10.1007/978-3-319-09665-0 $2 doi
035 $a 978-3-319-09665-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.H53
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 572.68 $2 23
090 $a QP99.3.H53 $b H638 2015
245 0 0 $a High density lipoproteins $h [electronic resource] : $b from biological understanding to clinical exploitation / $c edited by Arnold von Eckardstein, Dimitris Kardassis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xiii, 694 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.224
505 0 $a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
520 $a In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.
650 0 $a High density lipoproteins. $3 605161
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Pharmacology/Toxicology. $3 463455
650 2 4 $a Molecular Medicine. $3 463625
650 2 4 $a Human Physiology. $3 463624
650 2 4 $a Immunology. $3 402223
650 2 4 $a Cell Biology. $3 463594
700 1 $a Eckardstein, Arnold von. $3 605159
700 1 $a Kardassis, Dimitris. $3 605160
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 466630
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-09665-0
950 $a Biomedical and Life Sciences (Springer-11642)